Priothera

Latest News and Resources

Biotech Profile

Priothera – From Novartis Shelved Asset to Phase 3 in Five Years

4 August 2025

CDMO News

EUROAPI Enters Five-Year CDMO Agreement with Priothera

18 June 2024